A comparative analysis of in vitro expansion of natural killer cells of a patient with autoimmune haemolytic anaemia and ovarian cancer with patients with other solid tumours

Oncology Letters

Volumn 3, Issue 2, 2012, Pages 435-440

  Dedeepiya, Vidyasagar Devaprasad ^a   Terunuma, Hiroshi ^b   Deng, Xuewen ^b   Baskar, Subramani ^a   Manjunath, Sadananda Rao ^a   Senthilkumar, Rajappa ^a   Murugan, Palanisamy ^a   Thamaraikannan, Paramasivam ^a   Srinivasan, Thangavelu ^a   Preethy, Senthilkumar ^a,c   Abraham, Samuel J K ^a,d  

^a Nichi In Centre for Regenerative Medicine   (India)

^b Biotherapy Institute of Japan   (Japan)

^c Hope Foundation   (India)

^d UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Auto immune hemolytic anemia; Autologous immune enhancement therapy; CD3+CD56 cells; Natural killer cells; Red blood cell and natural killer cell antibodies

Indexed keywords

CARBOPLATIN; CD56 ANTIGEN; CISPLATIN; PACLITAXEL; PREDNISOLONE;

ADULT; AGED; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BREAST CARCINOMA; CASE REPORT; CELL EXPANSION; CELL FUNCTION; CHILD; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CYSTADENOCARCINOMA; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; IN VITRO STUDY; LUNG CARCINOMA; MALE; MEDICAL HISTORY; MULTIPLE CYCLE TREATMENT; NATURAL KILLER CELL; OMENTECTOMY; OVARY CANCER; PERIPHERAL BLOOD MONONUCLEAR CELL; RADIOFREQUENCY ABLATION; SCHOOL CHILD; SOLID TUMOR;

EID: 84855251231     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.498     Document Type: Article

References (23)

1. Goto S, Shirotani N, Hatakeyama M, et al: Clinical benefit of non-toxic therapy in patients with advanced cancer (opinion). Anticancer Res 22: 2461-2464, 2002.
2. Kimura H and Yamaguchi Y: A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma. Cancer 80: 42-49, 1997.
3. Takayama T, Sekine T, Makuuchi M, et al: Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 356: 802-807, 2000.
4. Kono K, Takahashi A, Ichihara F, et al: Prognostic significance of adoptive immunotherapy with tumor-associated lymphocytes in patients with advanced gastric cancer: a randomized trial. Clin Cancer Res 8: 1767-1771, 2002.
5. Imai K, Matsuyama S, Miyake S, Suga K and Nakachi K: Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence an 11-year follow-up study of a general population, Lancet 356: 1795-1799, 2000.
6. Montelli TC, Peraçoli MT, Gabarra RC, Soares AM and Kurokawa CS: Familial cancer: depressed NK-cell cytotoxicity in healthy and cancer affected members. Arq Neuropsiquiatr 59: 6-10, 2001.
7. Grunebaum E, Malatzky-Goshen E and Shoenfeld Y: Natural killer cells and autoimmunity. Immunol Res 8: 292-304, 1989.
8. Baxter AG and Smyth MJ: The role of NK cells in auto-immune disease. Autoimmunity 35: 1-14, 2002.
9. Cameron AL, Kirby B and Griffiths CE: Circulating natural killer cells in psoriasis. Br J Dermatol 149: 160-164, 2003.
10. French AR and Yokoyama WM: Natural killer cells and autoimmunity. Arthritis Res Ther 6: 8-14, 2004.
11. Conte R, Dinota A, Tazzari PL, Belletti D and Sermasi G: Analysis of natural killer cells in patients with idiopathic auto-immune hemolytic anemia. Vox Sang 56: 270-273, 1989.
12. Takada M, Terunuma H, Deng X, Dewan MZ, Saji S, Kuroi K, Yamamoto N and Toi M: Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach. Breast Cancer 18: 64-67, 2011.
13. Spanholtz J, Preijers F, Tordoir M, et al: Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process. PLoS One 6: E20740, 2011.
14. Hoffman PC: Immune hemolytic anemia - selected topics. Hematol Am Soc Hematol Educ Program 13-18, 2006.
15. Puthenparambil J, Lechner K and Kornek G: Auto-immune hemolytic anemia as a paraneoplastic phenomenon in solid tumors: a critical analysis of 52 cases reported in the literature. Wien Klin Wochenschr 122: 229-236, 2010.
16. Al-Matham K, Alabed I, Zaidi SZ and Qushmaq KA: Cold agglutinin disease in fibrolamellar hepatocellular carcinoma: a rare association with a rare cancer variant. Ann Saudi Med 31: 197-200, 2011.
17. Morris PG, Swords R, Sukor S, Fortune A, O'Donnell DM and Conneally E: Auto-immune hemolytic anemia associated with ovarian cancer. J Clin Oncol 26: 4993-4995, 2008.
18. Kim I, Lee JY, Kwon JH, et al: A case of auto-immune hemolytic anemia associated with an ovarian teratoma. J Korean Med Sci 21: 365-367, 2006.
19. Park SB, Kim JK, Kim KR and Cho KS: Imaging findings of complications and unusual manifestations of ovarian teratomas. Radiographics 28: 969-983, 2008.
20. Valent P and Lechner K: Diagnosis and treatment of auto-immune haemolytic anaemias in adults: a clinical review. Wien Klin Wochenschr 120: 136-151, 2008.
21. Dewan MZ, Takada M, Terunuma H, Deng X, Ahmed S, Yamamoto N and Toi M: Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients. Biomed Pharmacother 63: 703-706, 2009.
22. Felder KM, Hoelzle K, Heinritzi K, Ritzmann M and Hoelzle LE: Antibodies to actin in auto-immune haemolytic anaemia. BMC Vet Res 6: 18, 2010.
23. Terunuma H, Deng X, Dewan Z, Fujimoto S and Yamamoto N: Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections. Int Rev Immunol 27: 93-110, 2008.